BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2986153)

  • 61. Cardiovascular effects of vasopressin: some recent aspects.
    Liard JF
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S61-5. PubMed ID: 2434775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension.
    Rabito SF; Carretero OA; Scicli AG
    Hypertension; 1981; 3(1):34-8. PubMed ID: 7009426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional involvement of vasopressin in the maintenance of systemic arterial blood pressures after phenoxybenzamine or phentolamine administration: studies in Long-Evans and Brattleboro rats.
    Winn MJ; Gardiner SM; Bennett T
    J Pharmacol Exp Ther; 1985 Nov; 235(2):500-5. PubMed ID: 2865355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hemodynamic, hormonal, and drinking responses to reduced venous return in the dog.
    Thrasher TN; Keil LC; Ramsay DJ
    Am J Physiol; 1982 Sep; 243(3):R354-62. PubMed ID: 7114291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanism of inhibition of renin response to hypotension by atrial natriuretic factor.
    Scheuer DA; Thrasher TN; Keil LC; Ramsay DJ
    Am J Physiol; 1989 Jul; 257(1 Pt 2):R194-203. PubMed ID: 2546456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cyclosporine augments renal but not systemic vascular reactivity.
    Garr MD; Paller MS
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F211-7. PubMed ID: 2301592
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats.
    Osborn JW; Skelton MM; Cowley AW
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H628-37. PubMed ID: 3826404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reversal of Na+ retention in chronic caval dogs by verapamil: contribution of medullary circulation.
    Chou SY; Reiser I; Porush JG
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F642-8. PubMed ID: 1415735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in adrenergic pressor responses by calcium channel modulation in conscious dogs.
    Wynsen JC; Gross GJ; Brooks HL; Warltier DC
    Am J Physiol; 1987 Sep; 253(3 Pt 2):H531-9. PubMed ID: 2443022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tolerance to haemorrhage during vasopressin antagonism and/or captopril treatment in conscious sheep.
    Ullman JE; Hjelmqvist H; Lundberg JM; Rundgren M
    Acta Physiol Scand; 1992 Dec; 146(4):457-65. PubMed ID: 1492563
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cardiovascular effect of the antidiuretic hormone arginine vasopressin].
    Rascher W
    Klin Wochenschr; 1985 Oct; 63(19):989-99. PubMed ID: 4068606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiovascular and renal responses to chronic vasopressin infusion.
    Brown AJ; Lohmeier TE; Carroll RG; Meydrech EF
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H584-94. PubMed ID: 3515969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels.
    Riegger GA; Liebau G; Bauer E; Kochsiek K
    J Cardiovasc Pharmacol; 1985; 7(1):1-5. PubMed ID: 2580126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of vasopressin antagonist on water excretion in inferior vena cava constriction.
    Ishikawa S; Saito T; Okada K; Tsutsui K; Kuzuya T
    Kidney Int; 1986 Jul; 30(1):49-55. PubMed ID: 3747342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.